JP2009179581A - Agent for preventing body fluid leakage for corpse and apparatus for preventing and treating body fluid leakage - Google Patents

Abstract

<P>PROBLEM TO BE SOLVED: To provide a composition for preventing body fluid leakage from corpse. <P>SOLUTION: The agent for preventing body fluid leakage for corpse comprises (A) an alcohol-based organic solvent composed of an alcohol and a polyhydric alcohol, (B) a dispersion stabilizer of polyethylene oxide being a nonionic water-soluble thermoplastic resin and (C) a highly water-absorbing resin powder. <P>COPYRIGHT: (C)2009,JPO&INPIT

Description

Background of the Invention

The present invention relates to a body fluid leakage preventive agent and a body fluid leakage prevention treatment device for corpses.

Background Art The body of a corpse (human and animal cadaver) relaxes after dying, so that body fluids such as gastric juice, lung fluid, ascites, and excrement remain in the corpse's mouth, nose, ears, anus, and vagina. May leak from the holes (cavities) present in the For this reason, for example, in hospitals, after confirming death, a large amount of gauze, absorbent cotton, etc. is loaded in the hole (cavity) of the corpse to prevent body fluid from leaking from the corpse.

  However, in the method of loading gauze, absorbent cotton, etc., when there are a lot of body fluids, it may be difficult to absorb the fluid, so that the body fluids often leaked during or after the body treatment work. In addition, a bad odor due to the leaked bodily fluid was generated during the body treatment work, and there was a risk of post-mortem infection due to pathogenic bacteria, so workers (nurses, etc.) had difficulty with the treatment.

  In order to solve the above problems, Japanese Patent Laid-Open No. 10-298001 (Patent Document 1) proposes a method of loading superabsorbent resin powder in place of gauze, absorbent cotton, etc., and Japanese Patent Laid-Open No. 08-133901. In the gazette (Patent Document 2), a method is proposed in which a powder polymer containing a deodorant is dissolved and mixed with an appropriate amount of water to form a jelly.

  However, a bodily fluid leakage preventive agent that can effectively prevent leakage of bodily fluid from the corpse has not been developed yet, and its rapid development is desired at the site where corpse treatment is performed.

Summary of the Invention

  In the present invention, the present inventors have used a body fluid leakage preventive agent for corpses prepared by mixing a specific dispersion stabilizer in a bag with an alcohol-based organic solvent, a water-soluble thickening synergist and a superabsorbent resin powder. For example, the water absorption rate of bodily fluids is fast, and the gel solidified after water absorption makes it possible to prevent the body fluid remaining in the pores (cavities) from leaking from the dead body at a very high level. Got. The present invention has been made based on such knowledge.

Therefore, the present invention is a body fluid leakage preventing agent for corpses,
(A) an alcohol-based organic solvent comprising an alcohol or a polyhydric alcohol;
(B) As a dispersion stabilizer, polyethylene oxide which is a nonionic and water-soluble thermoplastic resin, and (C) a highly water-absorbing resin powder are provided.

1. Body fluid leakage preventing agent for corpses ( A) Alcohol-based organic solvent The alcohol-based organic solvent is composed of alcohols or polyhydric alcohols, and among these, those which are liquid at room temperature (about 25 ° C.) are preferable. More preferably, those soluble in water (polar solvent) are used.

  Specific examples of alcohols or polyhydric alcohols include lower alcohols such as ethanol, isopropanol, pentanol, hexanol, decanol; ethyl cellosolve, ethyl carbitol, ethylene glycol, diethylene glycol, triethylene glycol, propylene glycol, glycerin , Polyhydric alcohols such as polyethylene glycol (average molecular weight of polymerization is 500 or less); and polyoxyethylene alkyl (alkyl group has about 12 to 14 carbon atoms) ether (ethylene oxide added in 7 to 12 moles) Degree), higher alcohol type nonionic surfactants such as polyoxyethylene lauryl ether, polyoxyethylene cetyl ether, polyoxyalkylene alkyl ether, and the like. Or it can be used in a combination of two or more.

  Preferable specific examples of alcohols or polyhydric alcohols are preferably liquid polyethylene glycols (average molecular weight of polymerization degree is 200 to 500). This liquid polyethylene glycol (PEG) is preferable because it has a high flash point (241 ° C. to 244 ° C.), is completely dissolved in water and many organic solvents, and has excellent thermal stability. In this PEG, (B) a dispersion stabilizer, in particular, a nonionic, water-soluble thermoplastic resin polyethylene oxide powder (softening point 65 ° C. to 67 ° C.) dissolved at a high temperature (70 ° C. to 80 ° C.) (C) When a superabsorbent resin powder is added, it becomes possible to obtain a stable body fluid leakage preventive agent that is easily dispersed and mixed.

  This liquid polyethylene glycol has the property of being easily mixed and dissolved with water, and (C) the superabsorbent resin powder can be dispersed and mixed. Therefore, the bodily fluid leakage preventive agent according to the present invention has a very high water absorption rate and a high gel-solidifying ability, and thus quickly absorbs the liquid (solid mixture) substance remaining in the pores (cavities) of the corpse. And, it has the effect of solidifying rapidly into a hard gel with no fluidity.

  The content of the alcohol-based organic solvent is about 20% by mass to 90% by mass with respect to the total mass of the body fluid leakage preventing agent for corpses, preferably the lower limit is 30% by mass and the upper limit is 85% by mass. %, More preferably the lower limit is 40 mass% or more and the upper limit is about 80 mass% or less. By making the content of the alcohol-based organic solvent within the above range, the dispersibility of the superabsorbent resin powder is improved, and the superabsorbent resin powder is less likely to settle and separate even if left for a long time. Therefore, it becomes possible to fully exhibit the gel solidification ability of the body fluid leakage preventing agent for corpses.

(B) Dispersion stabilizer The dispersion stabilizer is mainly used for maintaining a uniform dispersion state of (C) the superabsorbent resin powder. In the present invention, polyethylene oxide which is a nonionic and water-soluble thermoplastic resin is used. The polyethylene oxide preferably has a molecular weight of about 100,000 to 8 million, more preferably a lower limit of 150,000 or more and an upper limit of about 2 million or less. The polyethylene oxide is preferably used in the form of a (white) powder. In the case of powder, the average particle size is about 10 mesh or more and 80 mesh or less, preferably the lower limit is about 15 mesh or more and the upper limit is about 50 mesh or less.

  According to a preferred embodiment of the present invention, as a dispersion stabilizer, a carboxyvinyl polymer of a crosslinked acrylic acid-based water-soluble resin, an alkali salt of a carboxyvinyl polymer of a crosslinked acrylic acid-based water-soluble resin, polyvinylpyrrolidone, polyurethane, and non- One or two types selected from the group consisting of polyalkylene oxides which are ionic and water-soluble thermoplastic resins can be further blended.

  The alkali salt of the carboxyvinyl polymer of the crosslinked acrylic acid-based water-soluble resin can be obtained by neutralizing the carboxyvinyl polymer of the crosslinked acrylic acid-based water-soluble resin with an alkaline substance. By neutralizing with an alkali, it is possible to increase the viscosity significantly. Examples of the alkali neutralizer include amines such as diethanolamine, triethanolamine, diisopropanolamine, di-2 (ethylhexyl) amine, triamylamine, dodecylamine, morpholine, sodium hydroxide, potassium hydroxide, water Examples thereof include inorganic salts such as ammonium oxide, aqueous ammonia, and the like. Among them, amines are preferable because they are easy to handle.

  Specific examples of polyalkylene oxide, which is a nonionic and water-soluble thermoplastic resin, include polyoxyethylene lauryl ether, polyoxyethylene cetyl ether, polyoxyethylene higher alcohol ether, polyethylene glycol (average molecular weight of polymerization degree) 600 or less), polyoxyethylene polyoxypropylene glycol (pluronic-type nonionic surfactant obtained by adding ethylene oxide to polypropylene glycol), polyoxyethylene alkyl (alkyl group having 12 to 14 carbon atoms) ether (number of moles of ethylene oxide added) : 7 to 12 moles) or a combination of two or more polyoxyethylene alkyl ethers.

  The content of the dispersion stabilizer is about 0.5% by mass to 40% by mass with respect to the total mass of the body fluid leakage preventing agent, preferably the lower limit is 1% by mass and the upper limit is 30% by mass. It is about the following. By making the content of the dispersion stabilizer within the above-mentioned range, it becomes possible to maintain uniform dispersibility of the superabsorbent resin powder, and it is possible to add a dispersion stabilizer economically. Become.

(C) Superabsorbent resin powder The superabsorbent resin powder may be any one as long as it has a high water absorbency, such as polyvinyl acrylate, polyacrylate, polyglutamate, polyalginate. , Crosslinked acrylic acid graft copolymer, copolymer of vinyl alcohol and polyacrylic acid, polyethylene glycol polymer, polyacrylamide resin, copolymer of maleic acid polyacrylate, polyethylene oxide polymer, and polyalginate Examples thereof include one or a combination of two or more selected from the group consisting of cross-linked polymers, acrylic acid graft copolymer cross-linked products, and starch / acrylate graft copolymer cross-linked products.

  The average particle size of the superabsorbent resin powder is about 20 mesh or more and 160 mesh or less (by Tyler display), preferably the lower limit is 30 mesh or more and the upper limit is about 150 mesh or less.

  The content of the superabsorbent resin powder is 5% by mass or more and 50% by mass or less, preferably the lower limit value is 15% by mass or more and the upper limit value is 35% by mass or less, based on the total mass of the body fluid leakage preventing agent. It is. By setting the content of the superabsorbent resin powder within the above-mentioned lower limit value and the limit value range, body fluid does not leak from the pores (cavities) in the dead body, and immediately absorbs and expands, resulting in no fluidity. As a solidified gel, it has the effect of being confined in the body.

(D) Water-soluble thickener According to the preferable aspect of this invention, it is preferable to mix | blend a water-soluble thickener. The water-soluble thickener stably maintains the soluble viscosity in the body fluid leakage preventing agent for corpses. The water-soluble synthetic thickener may be a natural material or a synthetic material, but a synthetic material is preferably used, and a synthetic material mainly composed of a clay mineral is more preferable. Specific examples of the clay mineral include allophane, hysinger gel, phyllosilicate, pyrophyllite, talc, mica, montmorillonite, montmorillonite (bentonite), vermiculite, ryokdeite, kaolin, inosilicate, and palygorskite. Specific examples of water-soluble (synthetic) thickeners include one or more selected from the group consisting of synthetic laponite, synthetic laponite / sodium pyrophosphate mixture, lipophilic synthetic smectite, and milkone. .

  In particular, water-absorbing synthetic thickeners of swellable clay minerals such as synthetic laponite, lipophilic synthetic smectite, and milcon are added to (B) dispersion stabilizers and mixed in (small amount) to make highly water-absorbent resin powder uniform And the viscosity of the body fluid leakage preventing agent is stably maintained by suppressing the separation of the alcoholic organic solvent. In this respect, it has a remarkable viscosity stability compared to that of natural materials.

  The content of the water-soluble synthetic thickener is about 0.1% by mass to 30% by mass with respect to the total mass of the body fluid leakage preventing agent, and preferably has a lower limit of 0.3% by mass or more and an upper limit. The value is about 15% by mass or less. By setting the content of the dispersion stabilizer within the above-described range, there is an effect of stably maintaining the viscosity of the body fluid leakage preventing agent for corpses.

(E) Arbitrary agent In the present invention, the corpse fluid leakage preventive agent, if necessary, optional agents such as bactericides, fungicides, antiseptics, deodorants, fragrances and pigments It is possible to add one or a combination of two or more. By adding an arbitrary agent, it becomes possible to impart the effect of each arbitrary agent to the body fluid leakage preventing agent for corpses.

  As the “bactericidal agent”, isopropylmethylphenol, chlorhexidine gluconate, thymol, o-phenylphenol, benzalkonium chloride, cetylpyridinium chloride, benzethonium chloride, triclosan, ε-polylysine, lysozyme chloride, hinokitiol, grapefruit seed extract, One kind or a combination of two or more kinds such as mustard extract (wasa auro) can be mentioned. As "antifungal" and "preservative", one or more of sodium paraoxybenzoate, butyl paraoxybenzoate, propyl paraoxybenzoate, isobutyl paraoxybenzoate, sodium benzoate, sodium propionate, thiabendazole, isothiazolone, etc. The combination of these is mentioned. The content of the “bactericidal agent, antifungal agent, and preservative” is about 0.001% by mass to 10% by mass, preferably about 0% with respect to the total mass of the body fluid leakage preventing agent for corpses. 0.005 mass% to 8 mass%.

  “Deodorant” includes Moso bamboo extract, green tea extract, long-chain betaine compound, deodorant based on generic tannin of persimmon extract, and plant-type special deodorant mixed with several plant extracts One kind or a combination of two or more kinds of agents and the like can be mentioned. The content of the deodorant is about 0.05% by mass to 20% by mass, preferably about 0.1% by mass to 10% by mass with respect to the total mass of the body fluid leakage preventing agent for corpses.

  Examples of the “fragrance” include various natural and artificial flavors such as floral, citrus, fruity, woody, fresh note, mixed flavor, green and mint. Examples of the “pigment” include natural colorants and synthetic colorants, and any of pigments and dyes can be used. Content of a fragrance | flavor is about 0.001 mass%-15 mass% with respect to the total mass of the bodily fluid leakage prevention agent for corpses, Preferably it is 0.01 mass%-8 mass%.

Preparation / Composition / Use The body fluid leakage preventive agent according to the present invention may be prepared by mixing (A) an alcohol-based organic solvent, (B) a dispersion stabilizer, and (C) a superabsorbent resin powder. According to a preferred embodiment of the present invention, a mixture of (A) an alcohol-based organic solvent, (B) a dispersion stabilizer, and (D) a water-soluble synthetic thickener is used as a basic agent. It is preferable to prepare by mixing and uniformly dispersing the resin powder.

  The viscosity of the body fluid leakage preventive agent according to the present invention is preferably about 5,000 to 60,000 cPs, more preferably about 8,000 to 40,000 cPs. The viscosity was measured using a viscometer (manufactured by Brookfield, USA, “digital viscometer” model: DV-1 +), spindle no. 07, rotation speed: 20 rpm, used body fluid leakage preventing agent temperature: 20 ° C.

The amount of the body fluid leakage prevention agent injected into the body hole (cavity) can be appropriately set according to the size, weight, etc. of the body, but is contained in the body fluid leakage prevention agent. The water-absorbing resin can be determined based on the water-absorbing performance. Specifically, the water-absorbing ability of solidifying 3,000 ml of water into a gel and preventing leakage of the liquid from the body cavity is only required. In general, the amount is preferably 5 to 60 g, more preferably 10 to 40 g, which can prevent leakage of body fluid. More specifically, for example, the filling amount of the body fluid leakage preventing agent (containing 5 to 50% by mass of the superabsorbent resin) used in the body processing apparatus that is injected into the throat from the mouth or nostril of the body is 8 to 40 g. Is more preferable, and 10 to 30 g is more preferable.
The injection amount of the body fluid leakage prevention agent for corpses is within the above range, so that the size of the injector can be easily used, and the body fluid can be easily solidified into a gel, which effectively prevents body fluid leakage. Can be prevented.

  The body fluid leakage preventive agent according to the present invention is used by filling the mouth, nose, ear, anus, and vagina of a human or animal body. Moreover, it utilizes as an corpse processing apparatus provided with an injection device (for example, syringe etc.) and the bodily fluid leakage prevention agent for corpses by this invention. From the viewpoint of work efficiency and safety, what is stored in an injector (such as a syringe) is preferably used. In addition, this syringe has a color, shape, pattern, etc. in order to clarify that it is for corpse treatment and to clearly distinguish and distinguish it from medical devices for animal, human diagnosis, treatment, and surgery. It is possible.

2. Body processing device (for nasal cavity or oral cavity)
According to another aspect of the present invention, there is provided a corpse treatment apparatus that introduces body fluid leakage prevention from the nasal cavity or oral cavity, and more specifically, the following.
Comprising an injector and an anti-body fluid leakage preventing agent according to the present invention;
The injector comprises a cylindrical main body having a discharge port at the tip, and a piston slidably inserted into the cylindrical main body from the rear end side,
A body treatment apparatus in which a body fluid leakage preventing agent for a body is accommodated in the cylindrical main body can be provided.

The contents of this body processing apparatus will be described below with reference to the drawings as necessary.
FIG. 1 schematically shows a nasal cavity or oral cavity introduction type body processing apparatus according to the present invention. The injector 1 in which the body fluid leakage preventing agent 2 according to the present invention is accommodated has an injection port in which a piston 3 is slidably inserted from the rear end portion and an optional protective cap 5 is covered on the tip. 4 and sealed in a film pack (not shown). The insertion tube 6 to be inserted into the throat B or the like has a connection portion 7 connected to the injection port 4 of the injector 1 at one end and an opening 8 to be inserted into the nostril A at the other end.

  When using the corpse processing apparatus, the injector 1 is taken out from the film pack, the protective cap 5 of the inlet 4 of the injector 1 is removed, and the connecting portion 7 of the insertion tube 6 is fitted to the injection port 4 so that the insertion tube 6 is inserted. Connecting. Next, the opening 8 of the insertion tube 6 is inserted from the nostril A toward the throat B, and the insertion is stopped when the stopper portion 9 of the insertion tube 6 hits the nose tip B. Then, the piston 3 of the injector 1 is pressed, and the jelly-like body fluid leakage preventing agent 2 in the injector 1 is injected into the throat B through the insertion tube 6. After the body fluid leakage preventing agent 2 in the injector 1 is extruded and filled, the injector 1 and the insertion tube 6 are removed from the nostril A. Although not shown, the corpse treatment apparatus according to the present invention can be inserted from the oral cavity. In this case, in FIG. 1, the opening 8 of the insertion tube 6 is inserted from the oral cavity toward the throat B, and the insertion is stopped when the stopper portion 9 of the insertion tube 6 hits the lips. Thereafter, it may be the same as described above.

Injector (body)
The body processing apparatus according to the present invention will be described in more detail with reference to FIGS.
2 to 4 show the injector 10, FIG. 4 shows a cross-sectional view of the state rotated by 90 ° around the center line from the state shown in FIG. 2. As shown in FIGS. 2 to 4, the injector 10 includes a cylindrical main body 20 and a piston 30 each made of a plastic such as high-density polyethylene, polypropylene, polyester, and polyamide. The cylindrical main body 20 includes a cylindrical member 21 having a discharge cylinder portion 22 that functions as a discharge port portion at the tip, and a cover member 25 that is crowned on the outer periphery thereof.

  According to a preferred aspect of the present invention, the cover member 25 is a cylinder having an octagonal cross section, as is apparent from FIG. 2, and is configured so that a nurse can easily discriminate it from a general syringe in a hospital. ing. Further, the cover member is not limited to an octagonal shape, and may be a polygonal shape or a cylindrical shape. The tip end side is formed in a slightly tapered shape so that it does not easily fall off when the cylindrical member 21 is inserted. It is configured. In addition, it is also possible to make it possible to clearly grasp the application place by coloring the cover member or coloring it differently from the color of other members to make a colorful injector. Such a configuration is preferable in the present invention.

  As clearly shown in FIG. 4, the cover member 25 preferably has a pair of flange portions 26 protruding outward in the radial direction for hooking a finger to the rear end portion. The distal end portion of the collar portion 26 is curved in the direction of the discharge cylinder portion 22 so that the finger can be easily caught. Further, a pair of convex locking portions 23 are formed at the rear end of the cylindrical member 21, and when the collar portion 26 comes into contact with the locking portion 23, a finger is hooked on the collar portion 26 and injected. More preferably, the cover member 25 is configured not to move rearward from the rear end of the cylindrical member 21 when operated. Moreover, the protective cap 29 is removably crowned at the distal end opening of the discharge cylinder portion 22 after the body fluid leakage preventing agent of the present invention is filled in the injector 10. In the present embodiment, the cylindrical member 21 and the cover member 25 are formed separately, but may be integrally formed.

  On the other hand, the piston 30 is slidably inserted into the cylindrical member 21 of the cylindrical main body 20 from the rear end side. The length of the piston 30 is designed to be longer than the length of the cylindrical member 21 so that the whole body fluid leakage preventing agent X of the contents can be pushed out. The piston 30 has a piston rod 31 having a cross-shaped cross section, and a circular flange portion 32 having a diameter slightly larger than the cross-sectional dimension of the piston rod is formed at the tip portion thereof. A gasket 34 made of synthetic resin, rubber or the like is crowned around the flange portion 33 formed so as to protrude from the circular flange portion 32. In addition, a disc-like portion 35 for touching the finger is formed at the rear end of the piston rod 31 so that the piston rod 31 can be easily pressed with the finger. When the piston 30 is inserted into the cylindrical member 21 of the cylindrical main body 20 from the rear end portion side, the piston 34 passes through the cylindrical member 21 with the gasket 34 in contact with the inner peripheral surface of the cylindrical member 21 of the injector 10. It is configured to slide. Further, a ring-shaped ridge portion 24 protruding slightly inward is formed on the inner peripheral surface in the vicinity of the rear end portion of the cylindrical member 21, and the circular flange portion of the piston rod 31 is formed on the ridge portion 24. The piston 30 is configured not to easily come out of the cylindrical main body 20 when it hits 32. In this embodiment, the piston rod 31 has a cross-shaped cross section, but may have a rod shape such as a circular cross section.

  According to a preferred aspect of the main body, as shown in FIG. 4, a corpse treatment device is proposed that further includes a stopper 50 that is disposed on the cylindrical main body 20 and protrudes toward the outer side of the cylindrical main body 20. . The stopper 50 may be disposed at any position on the cylindrical main body 20, but is preferably disposed on the discharge unit side. The length of the stopper 50 can be determined as appropriate, but the length in the outward direction (vertical direction) from the portion disposed on the cylindrical main body 20 is about 0 mm or more and 20 mm or less, and preferably the lower limit is 10 mm or more. The upper limit is about 18 mm or less. The length of the stopper 50 itself (parallel to the cylindrical main body 20) is about 30 mm or more and 55 mm or less, preferably the lower limit is 35 mm or more and the upper limit is about 50 mm or less. The shape of the stopper 50 can be determined as appropriate, but can be a cylinder, a triangular prism, a quadrangular prism, or the like.

The insertion tube insertion tube 40 is made of a flexible synthetic resin such as polyester elastomer, soft polyethylene, soft vinyl chloride resin, or rubber having flexibility to bend along the shape of the nasal cavity when inserted into the nostril. As shown in FIG. 5, the distal end 45 of the distal end portion 41 of the insertion tube 40 may be cut into any shape in the same manner as a normal tube (tube, catheter). According to a preferred embodiment of the present invention, as shown in FIG. 5, the distal end portion 41 of the insertion tube 40 is formed in a substantially hemispherical shape so as to be easily inserted from the nostril, and is closed on the side surface. In addition to having a pair of opening portions 42 in directions perpendicular to each other at two positions shifted from each other, the rear end portion is slightly expanded to the rear side for connection to the discharge cylinder portion 22 of the injector 10. What has the taper-shaped connection part 43 is preferable. In addition, a stopper section 44 having a circular cross section protruding outward in the radial direction so as to surround the outer periphery is provided at a position at a predetermined distance from the rear end of the insertion tube 40 (preferably the tip position of the connection portion 43). Furthermore, according to another aspect of the present invention, the insertion tube may be integrally formed with the injector (main body).

  The length of the insertion tube is preferably 90 to 200 mm, more preferably 100 to 160 mm, excluding the tapered connection portion located on the rear side for connection to the discharge portion of the injector 10. Further, the outer diameter of the insertion tube main body is preferably about 4.0 to 10.0 mm, more preferably 3.0 to 7.0 mm. The inner diameter is preferably about 3.0 to 9.0 mm, more preferably 2.0 to 6.0 mm.

  The opening portions 42 and 45 at the distal end of the insertion tube 40 can be holes having a desired shape such as a circle and an ellipse, and the position is preferably a distance of about 5 to 30 mm from the distal end of the insertion tube. Moreover, although the number of the opening parts 42 and 45 is four or five in this embodiment, it may be an arbitrary number of about 1 to 6. The stopper portion 44 determines the length (injection position) that the opening portion 42 reaches when the insertion tube main body is inserted into the pharynx through the nostril, but from the distal end of the insertion tube 40 to the stopper portion 44. Is preferably about 100 to 140 mm, and the outer diameter of the insertion tube body is preferably about 3.5 to 7 mm, and the inner diameter is preferably about 2 to 5 mm.

  In the above embodiment, the connection portion 43 is integrally formed at the rear end portion of the insertion tube 40, but the connection portion 43 may be a separate body. In this case, the connecting portion is preferably formed of a rigid synthetic resin, and the connecting portion and the insertion tube main body are joined by an appropriate means such as an adhesive or welding. Moreover, the stopper part 44 may be formed at the front end of the connection part, or may be formed at the rear end of the insertion tube. Furthermore, the insertion tube main body can be bent at a predetermined position from the distal end portion, and can be smoothly inserted without resistance when inserted from the nostril to the back of the pharynx. In this case, the bending position is preferably an arbitrary part having a distance of about 22 to 45 mm, more preferably about 20 to 30 mm from the distal end of the insertion tube main body, and the bending angle is preferably 0 to 95 °, more preferably. 30 to 70 °.

  As shown in FIG. 5, the insertion tube 150 may be detachable or attached to the injector body 20. The injection tube 150 has a discharge port 151 at the distal end, and a curved portion 152 that is curved from the distal end by a predetermined length. The curved portion 152 and the discharge portion 151 have a flat annular cross section whose dimension in the direction toward the curved direction is smaller than that of the method perpendicular thereto, and even if the curved surface shape of the corpse is slightly different, it is easy Therefore, the insertion tube 150 can be easily inserted through the body's mouth. At the rear end portion of the insertion tube 150, a cylindrical pair of external connection portions 153 fitted to the distal end portion of the cylindrical main body 20, and an inner cylindrical shape of the cylindrical main body 20 are arranged inside the external connection portion 153. A tapered internal connection portion 154 into which the tapered internal connection portion 113 of the body 21 is fitted is formed, and these lead to the bending portion 152 through the connection 155.

  The external connection portion 153 in the insertion tube 150 functions as a stopper portion or an insertion stop position display portion when the bending portion 152 is inserted from the body's mouth toward the throat, so that the external discharge portion 151 is externally connected. The length to the connection part 153 can be about the length that the ejection part 151 reaches the pharynx through the mouth. Further, the major axis outer dimension of the flat annular cross section of the curved portion 152 is about 5 to 25 mm, preferably about 10 to 15 mm, and the minor axis outer dimension is about 3 to 15 mm, preferably about 5 to 10 mm. I just need it. In addition to the discharge port 151, one or a plurality of holes may be provided on the tip side surface of the bending portion 152.

Method of Use When using the corpse treatment apparatus, first, the protective cap 29 of the discharge tube portion 22 of the injector 10 is removed, and the discharge tube portion 22 is fitted into the connection portion 43 of the insert tube 40 to insert the insert tube 40 and the injector 10. Connect. Next, the insertion tube 40 is inserted from the nostril A (see FIG. 1) toward the throat B, and the insertion is stopped when the stopper portion 44 of the insertion tube 40 hits the tip of the nose. At this time, a lubricant may be applied to the insertion tube 40 in order to reduce the insertion resistance. Then, the piston 30 of the injector 10 is pressed, and the jelly-like body fluid leakage preventing agent X in the injector 10 is injected into the throat B through the insertion tube 40. After the body fluid leakage preventing agent X in the injector 10 is extruded and filled, the injector 10 and the insertion tube 40 are extracted from the nostril A.

  In the above operation method, the insertion tube 40 is inserted into the nostril A while being connected to the injector 10. However, the insertion tube 40 may be inserted into the nostril A first, and then the injector 10 may be connected to the insertion tube 40. . Further, the injector 10 and the insertion tube 40 may be stored in a container in a connected state, and in this case, the treatment work can be performed immediately after being taken out from the container. Alternatively, in the above-described embodiment, the injector 10 and the insertion tube 40 are separate bodies, but they may be integrally manufactured. Further, even if a mark is provided instead of the stopper portion 44 formed on the insertion tube 40, variations in the insertion position can be prevented to some extent.

3. Body processing device (for anus or vagina)
According to another aspect of the present invention, a corpse treatment apparatus for injecting corporal body fluid leakage prevention into the anus or vagina can be provided. More specifically,
Comprising an injector and a body fluid leakage prevention agent for corpses,
The injector comprises a cylindrical main body having a discharge port at the tip, and a piston slidably inserted into the cylindrical main body from the rear end side,
A body treatment apparatus in which a body fluid leakage preventing agent for a body is accommodated in the cylindrical main body can be provided.
According to a preferred aspect of the present invention, the body for anus or vagina, in which the sealing material and the body fluid leakage preventing agent for the body are accommodated in the cylindrical body from the piston side in this order. A processing device can be provided.

The contents of this body processing apparatus will be described below with reference to the drawings as necessary.
6 to 8 show the injector 10a. FIG. 8 shows a cross-sectional view of the injector 10a rotated by 90 ° around the center line from the state shown in FIG. As shown in FIGS. 6 to 8, in this embodiment as well, the injector 10 a is a cylindrical body made of a plastic such as high-density polyethylene, polypropylene, polyester, polyamide, etc. 20a and the piston 30 are comprised. However, the sealing material Y is accommodated in the injector 10a together with the body fluid leakage preventing agent X for corpse. In this sealing material Y, after the body fluid leakage preventing agent X becomes a solid gel in the body cavity of the anus or vagina, the muscles in each part of the body cavity relax after death and a gap is formed between the solid gel. However, although it is for ensuring prevention of a bodily fluid leak, the contained thing can also be only the bodily fluid leak preventive agent X for corpses.

Body fluid leakage preventing agent for corpse The body fluid leakage preventing agent for corpse may be according to the present invention. Moreover, it may comprise at least (D) a superabsorbent resin powder (preferably only this). The amount of body fluid leakage preventive agent X contained in one device is about 1 to 10 g, more preferably about 1 to 5 g, the length of the filler Y is about 10 to 30 mm, and the diameter is about 8 to 23 mm. It is preferable to set within.

  The cylindrical main body 20a includes a cylindrical member 21a having a discharge port portion 22a at the tip, and a cover member 25a covered with an outer periphery thereof. The discharge port portion 22a at the tip of the cylindrical member 21a is formed in a substantially hemispherical shape (a slit may be provided in the discharge port portion if necessary). If a cylindrical syringe (syringe) with a large outer diameter is inserted into the anus or vagina after the death until it stiffens, the anal canal and the ostium of the vagina will open widely and it will take time to contract, which may cause fluid leakage. Become. Further, the thinner the cylindrical member 21a, the easier it is to insert and the easier it is to use. Accordingly, the outer diameter of the cylindrical member 21a is preferably set within a range of about 10 to 25 mm, more preferably about 10 to 15 mm, and the inner diameter is set within a range of about 8 to 23 mm.

  As is clear from FIG. 6, the cover member 25a is a cylinder having an octagonal cross section. However, the cover member 25a is not limited to an octagon, and may be a polygon or a cylinder. It is configured so that a nurse can easily distinguish it from a general syringe in a hospital. In addition, it is also possible to make it possible to clearly grasp the application place by coloring the cover member or coloring the cover member so that it is different from the color of other members to form a colorful injector. As clearly shown in FIG. 8, the cover member 25a has a cap-shaped stopper portion 27 that expands rearward at the front end portion thereof, and projects outward in the radial direction for hooking a finger to the rear end portion. The pair of flange portions 26 is provided. The distance from the tip of the cylindrical member 21a to the stopper portion 27 is preferably set within a range of about 15 to 50 mm, and the height of the stopper portion 27 from the outer peripheral surface of the cylindrical member 21a is easily set to the anus or vagina. It is preferable to set within a range of about 5 to 30 mm so as to stop at the mouth. The stopper portion 27 is not necessarily required to have a cap shape as in this embodiment, and a member that can ensure that no further insertion is performed at a position where the injector 10 is inserted into the anus or vagina by a predetermined length. Alternatively, it may be a mark, for example, a disk shape, or a mark that can be easily visually confirmed. Further, the distal end portion of the collar portion 26 is curved in the direction of the discharge port portion 22a so that the finger can be easily caught. It is preferable that the height of the collar portion 26 from the outer peripheral surface of the cylindrical member 21a is set within a range of about 5 to 18 mm, and the degree of curvature of the tip portion is within a range of 0 to 50 °. When such a cover member is used, the above-described collar portion and the stopper portion may be provided at predetermined positions of the cover member. Preferably, as in the present embodiment, the stopper portion is the tip of the cover member or the cover member. When the length is the same as that of the cylindrical member, it is desirable to provide the substantially intermediate portion and the collar portion at the rear end portion of the cover member.

  Further, a pair of convex locking portions 23 are formed at the rear end of the cylindrical member 21a, and when the collar portion 26 comes into contact with the locking portions 23, a finger is hooked on the collar portion 26 and injected. When the operation is performed, the cover member 25a is configured not to move backward from the rear end of the cylindrical member 21a. Further, the protective cap 29a is removably crowned at the tip of the cylindrical member 21a after the injector 10 is filled with the bodily fluid leakage preventing agent of the present invention. Also in this embodiment, the cylindrical member 21a and the cover member 25a are formed separately, but may be integrally formed.

  On the other hand, the structure of the piston 30 is the same as that of the above embodiment, and is slidably inserted into the cylindrical member 21a of the cylindrical main body 20a from the rear end side. The length of the piston 30 is designed to be longer than the length of the cylindrical member 21a so that the body fluid leakage preventing agent X and the sealing material Y of the contents can all be pushed out. The piston 30 has a piston rod 31 having a cross-shaped cross section, and a circular flange portion 32 having a diameter slightly larger than the cross-sectional dimension of the piston rod is formed at the tip portion thereof. A gasket 34 made of synthetic resin, rubber or the like is crowned around the flange portion 33 formed so as to protrude from the circular flange portion 32. In addition, a disc-like portion 35 for touching the finger is formed at the rear end of the piston rod 31 so that the piston rod 31 can be easily pressed with the finger.

  When the piston 30 is inserted into the cylindrical member 21a of the cylindrical main body 20 from the rear end side, the piston 30 passes through the cylindrical member 21a with the gasket 34 in contact with the inner peripheral surface of the cylindrical member 21a of the injector 10. It is configured to slide. Furthermore, a ring-shaped ridge 24 protruding slightly inward is formed on the inner peripheral surface in the vicinity of the rear end portion of the cylindrical member 21a, and the circular flange portion of the piston rod 31 is formed on the ridge 24. The piston 30 is configured not to easily come out of the cylindrical main body 20 when it hits 32. In this embodiment, the piston rod 31 has a cross-shaped cross section, but may have a rod shape such as a circular cross section.

  When using the treatment device for injecting and loading the body fluid leakage preventing agent X and the sealing material Y into the anus and / or vagina, first, without removing the protective cap 29a of the discharge port portion 22a of the injector 10a. For example, it is inserted into the anus or vagina as it is, and the insertion is stopped when the stopper portion 27 hits the outside of the anus or vagina. At this time, a lubricant may be applied to the protective cap 29a in order to reduce insertion resistance. Then, the piston 30 of the injector 10a is pressed, and the body fluid leakage preventing agent X and the sealing material Y in the injector 10a are injected together with the protective cap 29a. At that time, the superabsorbent resin powder in the bodily fluid leakage preventing agent X that has absorbed the bodily fluid and the liquid in the filth swells, and part of it penetrates into the sealing material Y and becomes a solid gel. It is possible to effectively prevent leakage of body fluids and filth. Thereafter, the injector 10a is extracted from the anus and vagina.

Filler filler Y is a substance that absorbs liquid and expands more than its original volume to prevent leakage of body fluid (for example, a compressed fibrous body), which is porous. A substance that does not expand (such as natural or synthetic sponges) is used. Specific examples of the compressed fibrous material include nonwoven fabrics of superabsorbent resin fibers, compressed pulp paper, cotton, cotton and superabsorbent resin fiber blends, molded articles of superabsorbent resin fibers, synthetic fiber nonwoven fabrics, cloths, etc. In particular, Runseal (registered trademark) F or Runseal (registered trademark) K made by Toyobo Co., Ltd., which is composed of an inner layer of water-swellable fiber, for example, acrylic fiber and an outer layer made of water-absorbing resin, is It is preferable to use a columnar shape or a compression-molded pulp of a pulp (eg, a female tampon type). Specific examples of natural or synthetic sponge bodies include sponges such as urethane and PET. Furthermore, according to another aspect of the present invention, a filler that absorbs liquid and expands from its own original volume to prevent leakage of bodily fluids can also be used preferably, for example, hydrophilic swelling sponges (for example, INOAC Corporation). And a water-absorbing swellable polyethylene glycol-based PU gel porous sponge (manufactured by Nisshinbo Co., Ltd., trade name, AGP).

  A treatment apparatus for injecting and loading a bodily fluid leakage prevention agent into the throat by inserting through the nostril as described above, and a treatment apparatus for injecting and loading the bodily fluid leakage prevention agent into the anus and / or vagina include an ear hole and It is preferable that the body treatment apparatus unit is configured to be housed in one container together with a fiber sealing material for preventing leakage of body fluid from the nostril, or a fiber sealing material for loading in the mouth, As a result, it is convenient to carry and the body can be treated quickly.

4). Set of mortuary treatment apparatus According to another preferred embodiment of the present invention, a corpse treatment apparatus set for preventing leakage of bodily fluid from the corpse is proposed,
A corpse treatment device according to the present invention for injecting a body fluid leakage preventing agent into the throat by inserting from the nasal cavity or oral cavity,
A corpse treatment device according to the present invention for injecting a body fluid leakage preventing agent from the anus or vagina, and a sealing material for preventing body fluid from leaking from the ear and / or nostril.

  The sealing material for preventing leakage of body fluid from the ear hole and nostril may be the same as the sealing material Y described above, but preferably cotton, highly water-absorbing resin fiber, cotton and highly water-absorbing resin What consists of a fiber blend and a nonwoven fabric, and shape | molded in desired shapes, such as spherical shape, column shape, and a cube, can be used suitably. It is preferable to provide two sealants for earplugs and two sealants for nasal plugs.

  Also, the fiber sealing material for loading in the mouth is intended to be placed in the cheek to prevent leakage of bodily fluids and to form the bulge of the cheek in the direction close to the natural bulge. , Cotton and superabsorbent resin fiber blend, cloth or non-woven fabric such as superabsorbent resin fiber, or non-woven fabric of cotton and superabsorbent resin fiber, or a sandwich of these single component members in any layer structure The sealing material which consists of the member laminated | stacked on can be used suitably.

EXAMPLES The contents of the present invention will be described with reference to the following examples, but the contents of the present invention should not be construed as being limited to the contents of the following examples.

Preparation of body fluid inhibitor for corpse In a composition ratio shown in Tables 1 and 2 below, (A) a viscous liquid base prepared by dissolving (B) a dispersion stabilizer in an alcohol-based organic solvent (polyethylene glycol 200), (C ) A body fluid leakage preventing agent for a corpse was prepared by uniformly dispersing a superabsorbent resin powder. In addition, a water-soluble thickening agent (D) that stably maintains water-soluble viscosity was added to the formulation to prepare a body fluid leakage preventing agent for corpses. The numbers in Tables 1 and 2 represent “mass%”.

Substance PEG200 used in the composition table of Table 1 : Polyethylene glycol having an average molecular weight of 200 for the degree of polymerization. (Nippon Yushi Co., Ltd.)
Polyethylene oxide: Trade name “Peo-1Z” manufactured by Sumitomo Seika Co., Ltd.
Carboxy vinyl polymer: Product name “Hibiswako” manufactured by Wako Pure Chemical Industries, Ltd.
Polyvinyl pyrrolidone: Trade name “Pitscol” manufactured by Daiichi Kogyo Seiyaku Co., Ltd.
Polyurethane: Trade name “Viscostar” manufactured by Mitsui Takeda Chemical Co., Ltd.
Thermoplastic nonionic water-absorbing resin: Product name “Aqua Coke” manufactured by Sumitomo Seika Co., Ltd.
Synthetic smectite: Trade name “Smectite SPN” manufactured by Coop Chemical Co., Ltd.
Synthetic laponite: Trade name “Laponite” manufactured by Nippon Silica Industry Co., Ltd. Superabsorbent resin powder: Trade name “Aquakeep” manufactured by Sumitomo Seika Co., Ltd.

Substance PEG200 used in the composition table of Table 2 : Polyethylene glycol having an average molecular weight of 200 in the degree of polymerization. (Nippon Yushi Co., Ltd.)
Polyethylene oxide: Trade name “Peo” manufactured by Sumitomo Seika Co., Ltd.
Synthetic laponite: trade name “Laponite RD” manufactured by Nippon Silica Kogyo Co., Ltd.
Synthetic smectite: Trade name “Smectite SPN” manufactured by Coop Chemical Co., Ltd.
Mircon: Trade name “Milcon SP” manufactured by Showa Mining Co., Ltd.
Carboxy vinyl polymer: Product name “Hibiswako” manufactured by Wako Pure Chemical Industries, Ltd.
Methylcellulose: Trade name “Metroose” manufactured by Shin-Etsu Chemical Co., Ltd.
Carrageenan: Trade name “Takaragen AFT-F4” manufactured by Takaragen Co., Ltd.
Kitan Sangam / Locust Beam Mix: Trade name “Takaragen TLX-25” manufactured by Takaragen Co., Ltd.
Superabsorbent resin powder: Trade name “AQUAKEEP” manufactured by Sumitomo Seika Co., Ltd.

Evaluation Test The appearance gel state and the water absorption rate of each of the body fluid leakage preventing agents prepared above were evaluated by the following test methods, and the results are shown in Tables 1 and 2.
Evaluation 1: Gel condition evaluation Weigh 1 g of a test sample into a 100 ml beaker, and then gently inject 80 ml of ion-exchanged water (20 ° C.) to determine the time until all ion-exchanged water becomes jelly. It was measured. This was repeated three times to obtain an average value.
Evaluation 2: Gel appearance visual evaluation The appearance gel state of the jelly-like product obtained in Evaluation 1 was visually observed and evaluated according to the following criteria.
Evaluation criteria Evaluation A: The water absorption speed was high, the gel was discharged without resistance from the insertion tube of the injector, and no change was observed in the gel state even after standing for a long time.
Evaluation B: The gel was discharged without resistance from the insertion tube of the injector, but the gel was soft and difficult to produce.
Evaluation C: The gel was discharged without resistance from the insertion tube of the injector, but when left for a long time, the solvent slightly separated on the upper surface of the gel, making it difficult to produce a product.
Evaluation D: Although the gel was discharged without resistance from the insertion tube of the injector, the gel separated when left for a long time and was unsuitable for commercialization.
Evaluation E: The viscosity of the gel was so strong that it was difficult to fill the injector and it was difficult to be discharged from the insertion tube.
Evaluation F: The gel was hard and was not discharged from the insertion tube of the injector.

It is a schematic sectional drawing which shows the use condition of the corpse treatment apparatus by this invention. The one embodiment of the corpse treatment apparatus by this invention is shown, (A) is a front view, (B) is a left view, (C) is a right view. It is a longitudinal cross-sectional view along the center axis line of the corpse treatment apparatus shown in FIG. It is a cross-sectional view along the central axis of the corpse treatment apparatus shown in FIG. It is a longitudinal cross-sectional view which shows the insertion tube of the corpse treatment apparatus which concerns on this invention. The other embodiment of the corpse treatment apparatus which concerns on this invention is shown, (A) is a front view, (B) is a left view, (C) is a right view. It is a longitudinal cross-sectional view along the center axis line of the corpse treatment apparatus shown in FIG. It is a cross-sectional view along the central axis of the body treatment apparatus shown in FIG.

Claims (12)

(A) an alcohol-based organic solvent comprising an alcohol or a polyhydric alcohol;
(B) A body fluid leakage preventing agent for a corpse comprising, as a dispersion stabilizer, polyethylene oxide which is a nonionic water-soluble thermoplastic resin, and (C) a superabsorbent resin powder.   (D) The body fluid leakage preventing agent for corpses according to claim 1, further comprising a water-soluble thickener.   (B) As a dispersion stabilizer, a carboxyvinyl polymer of a crosslinked acrylic acid-based water-soluble resin, an alkali salt of a carboxyvinyl polymer of a crosslinked acrylic acid-based water-soluble resin, polyvinylpyrrolidone, polyurethane, and a nonionic water-soluble The body fluid leakage preventing agent for corpses according to claim 1 or 2, further comprising one or more selected from the group consisting of polyalkylene oxides which are thermoplastic resins.   The body fluid leakage prevention for corpse according to any one of claims 1 to 3, further comprising at least one selected from the group consisting of bactericides, fungicides, antiseptics, deodorants, fragrances and pigments. Agent.   A body processing apparatus comprising an injector and the body fluid leakage preventing agent for body according to any one of claims 1 to 4. The injector includes a cylindrical main body having a discharge port at the tip, and a piston slidably inserted into the cylindrical main body from the rear end side.
The body treatment apparatus according to claim 5, wherein the body fluid leakage preventing agent for a body is accommodated in the cylindrical main body.   The corpse treatment apparatus according to claim 6, further comprising a stopper that is disposed on the cylindrical main body and protrudes toward an outer portion of the cylindrical main body.   The body treatment apparatus according to claim 6 or 7, which is inserted from the nasal cavity or the oral cavity and injects a body fluid leakage preventing agent into the throat.   The corpse treatment apparatus of Claim 6 or 7 for inject | pouring the bodily fluid leakage prevention agent for a corpse from the anus or the vagina.   The body treatment apparatus according to claim 9, wherein a sealing material and a body fluid leakage preventing agent are housed in the cylindrical main body in this order from the piston side. A corpse treatment device set for preventing body fluid from leaking from the corpse,
A corpse treatment device according to claim 8, which is inserted from the nasal cavity or the oral cavity and injects a humor leakage preventive agent into the throat.
A body treatment apparatus according to claim 9 or 10 for injecting a body fluid leakage preventive agent from the anus or vagina, and a sealing material for preventing body fluid from leaking from the ear hole and / or nostril. The body processing equipment set.   The corpse treatment apparatus set according to claim 10, wherein the corpse fluid leakage preventing agent accommodated in the corpse treatment apparatus according to claim 7 comprises at least the (C) superabsorbent resin powder.

Images